C5ORF22 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.58935103861313E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.33808586012219E-13 |
Normal-vs-Stage2 |
4.37810000000205E-05 |
Normal-vs-Stage3 |
2.97739999322033E-09 |
Normal-vs-Stage4 |
4.91100005106659E-09 |
Stage1-vs-Stage2 |
5.606400E-01 |
Stage1-vs-Stage3 |
6.905000E-01 |
Stage1-vs-Stage4 |
4.977800E-01 |
Stage2-vs-Stage3 |
4.271800E-01 |
Stage2-vs-Stage4 |
3.449800E-01 |
Stage3-vs-Stage4 |
8.149600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.26283444707087E-12 |
Normal-vs-AfricanAmerican |
2.06359995758021E-09 |
Normal-vs-Asian |
4.078600E-01 |
Caucasian-vs-AfricanAmerican |
2.756200E-01 |
Caucasian-vs-Asian |
8.958000E-02 |
AfricanAmerican-vs-Asian |
2.296200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.18123346846278E-13 |
Normal-vs-Female |
5.76290015708025E-10 |
Male-vs-Female |
3.259400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.53300000027556E-07 |
Normal-vs-Age(41-60Yrs) |
2.03550509780825E-11 |
Normal-vs-Age(61-80Yrs) |
1.90690019330475E-10 |
Normal-vs-Age(81-100Yrs) |
4.43060000000495E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.059200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.395600E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.021800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.659000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.156400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.660800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.223310E-03 |
Normal-vs-Grade 2 |
4.76530004345221E-09 |
Normal-vs-Grade 3 |
3.4617864130837E-12 |
Normal-vs-Grade 4 |
1.99040006698681E-10 |
Grade 1-vs-Grade 2 |
6.078800E-01 |
Grade 1-vs-Grade 3 |
9.878200E-01 |
Grade 1-vs-Grade 4 |
7.409600E-01 |
Grade 2-vs-Grade 3 |
1.391250E-01 |
Grade 2-vs-Grade 4 |
7.873900E-02 |
Grade 3-vs-Grade 4 |
4.621200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.00279995208075E-09 |
Normal-vs-ccB subtype |
8.61030002852203E-09 |
ccA subtype-vs-ccB subtype |
7.081000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.8307000360096E-09 |
Normal-vs-N1 |
9.396500E-03 |
N0-vs-N1 |
7.913600E-01 |
|
|